NCT06011044 is a NA clinical trial of Intercostal Nerve Block in Intercostal Nerve Block, sponsored by Bixin Wen.

Who is sponsoring NCT06011044?

NCT06011044 is sponsored by Bixin Wen.

What drugs are being tested in NCT06011044?

Interventions in NCT06011044: Intercostal Nerve Block.

What condition does NCT06011044 study?

NCT06011044 studies Intercostal Nerve Block.

Is NCT06011044 still recruiting?

NCT06011044 is currently status unknown. Last updated 25 August 2023.

Last reviewed 2023-08-25 · How we verify

NCT06011044

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intercostal Nerve Block With Local Anesthesia Administered Via Incision-specific Multi-site Injection for Thoracic Surgery

Status unknown NA Last updated 25 August 2023

What this trial tests

NA trial testing Intercostal Nerve Block in Intercostal Nerve Block in 60 participants. Status unknown.

Timeline

19 August 2023

Primary endpoint
19 October 2023

19 October 2023

Quick facts

Lead sponsor	Bixin Wen
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	60
Start date	19 August 2023
Primary completion	19 October 2023
Estimated completion	19 October 2023

Drugs / interventions tested

Intercostal Nerve Block — full drug profile →

Conditions studied

Intercostal Nerve Block — all drugs for Intercostal Nerve Block →

Sponsor

Bixin Wen

Who can join

18 and older, any sex, with Intercostal Nerve Block. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to test analgesic effect of intercostal nerve block in different range. The main question it aims to answer are: question 1: whther incision-specific multi-site injection (ISMSI, from the 3rd to 8th intercostal nerve) can improve the analgesic benefits . The participants will be divided into three groups to compare the analgesic effects of different intercostal nerve blocks

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Intercostal Nerve Block

Trials testing the same drug.

NCT07386626 — Tegileridine Combined With Intercostal Nerve Block After Thoracoscopic Lung Resection · NA · recruiting
NCT04835922 — Comparison of Efficacy of Intercostal Nerve Block vs Peritract Infiltration With 0.25% Bupivacaine in PCNL · NA · unknown

Other recruiting trials for Intercostal Nerve Block

Currently open trials in the same condition.

NCT07250373 — Serratus Posterior Superior Intercostal Plane (SPSIP) Block Versus Intercostal Nerve (ICN) Block in Patients Undergoing · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06011044 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bixin Wen
Last refreshed: 25 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06011044.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing